Cargando…
Aquaporin 9 inhibits hepatocellular carcinoma through up-regulating FOXO1 expression
Aquaporin 9 (AQP9) is the main aquaglyceroporin in the liver. Few studies have been performed regarding the role of AQP9 in liver cancer. Here we report AQP9 expression and function in liver cancer. We found that AQP9 mRNA and protein levels were reduced in human hepatocellular cancer compared to th...
Autores principales: | Li, Chuan-Fei, Zhang, Wen-Guang, Liu, Min, Qiu, Lie-Wang, Chen, Xiao-Feng, Lv, Lin, Mei, Zhe-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190086/ https://www.ncbi.nlm.nih.gov/pubmed/27329843 http://dx.doi.org/10.18632/oncotarget.10143 |
Ejemplares similares
-
Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via Wnt/β-catenin pathway
por: Liao, Shengtao, et al.
Publicado: (2020) -
Prognostic Value of Combined Aquaporin 3 and Aquaporin 5 Overexpression in Hepatocellular Carcinoma
por: Guo, Xiaodong, et al.
Publicado: (2013) -
Metformin inhibits hepatocellular carcinoma development by inducing apoptosis and pyroptosis through regulating FOXO3
por: Shen, Zetian, et al.
Publicado: (2021) -
AQP9 (Aquaporin 9) Determines Arsenic Uptake and Tolerance in Human Hepatocellular Carcinoma Cells In Vitro
por: Yao, Dingyan, et al.
Publicado: (2022) -
PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma
por: Zhang, Shi-Zhe, et al.
Publicado: (2021)